Evidence map›Paper›PMID 31367007›Full record

ArticleScientific reports2019

Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer.

Dhruvitkumar S Sutaria, Jinmai Jiang, Ana Clara Azevedo-Pouly, Lais Wright, Julie A Bray, Kristianna Fredenburg, Xiuli Liu, Jun Lu, Carolina Torres, Georgina Mancinelli and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The Role of MicroRNAs in Pancreatitis Development and Progression.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. miR-217-5p Inhibits Invasion and Metastasis of Prostate Cancer by Targeting Clusterin.Mammalian genome : official journal of the International Mammalian Genome Society · 2021
    Article
  10. Review
  11. Florida-California Cancer Research, Education and Engagement (CaRECancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Dhruvitkumar S SutariaDepartment of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Jinmai JiangDepartment of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Ana Clara Azevedo-PoulyNational Center for Toxicological Research, Food and Drug Administration, Jefferson, AR, USA.
Lais WrightDepartment of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Julie A BrayDepartment of Pathology, University of Florida, Gainesville, Florida, USA.
Kristianna FredenburgDepartment of Pathology, University of Florida, Gainesville, Florida, USA.
Xiuli LiuDepartment of Pathology, University of Florida, Gainesville, Florida, USA.
Jun LuDepartment of Pathology, Beijing Chaoyang Hospital, Capital University, Beijing, China.
Carolina TorresDepartment of Medicine, University of Illinois, Chicago, Illinois, USA.
Georgina MancinelliDepartment of Medicine, University of Illinois, Chicago, Illinois, USA.ORCID http://orcid.org/0000-0002-5216-7086
Paul J GrippoDepartment of Medicine, University of Illinois, Chicago, Illinois, USA.
Vincenzo CoppolaDepartment of Cancer Biology and Genetics, College of Medicine and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Thomas D SchmittgenDepartment of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA. tschmittgen@ufl.edu.
University of Florida · USUniversity of Illinois Chicago · USBeijing Chao-Yang Hospital, Capital Medical University · CNNational Center for Toxicological Research · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
The Novel Role of REST in the Development of Pancreatic Ductal AdenocarcinomaF31CA220937 · NCI · UNIVERSITY OF FLORIDA · PI BRAY, JULIE · 2017 to 2019
$99k
NCI NIH HHS F31 CA220937NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

The pancreatic acinar-enriched miR-216a, miR-216b and miR-217 are encoded within the miR217HG. These miRNAs have been purported to play a tumor suppressive role as their expression is reduced in both human and mouse pancreatic ductal adenocarcinoma (PDAC). To examine this possibility, we generated individual, germline knockout (KO) mice of miR-216a, miR-216b or miR-217. Unlike our previous study showing germline deletion of the miR217HG was embryonic lethal, CRISPR-Cas9 deleted portions of the 5' seed region of the miRNAs produced live births. To investigate possible phenotypes during pancreatic acinar ductal metaplasia (ADM), pancreatic acini from wild type and KO mice were plated on collagen and allowed to transdifferentiate over 4 days. Acini from each of the three miRNA KO mice produced greater numbers of ducts compared to controls. Evaluation of the gene expression during in vitro ADM demonstrated an increase in Krt19 and a reduction in acinar genes (Carboxypeptidase A1, Amylase2a) on day 4 of the transdifferentiation. Recovery was delayed for the miR-216a and miR-216b KOs following caerulein-induced acute pancreatitis. Also predominate in the caerulein treated miR-216a and miR-216b KO mice was the presence of pancreatic duct glands (PDGs). To further establish a phenotype, miRNA KO mice were crossed with EL-KRAS

Indexed as

Acinar CellsAnimalsCarcinoma in SituCarcinoma, Pancreatic DuctalCell TransdifferentiationCell Transformation, NeoplasticGene ExpressionMiceMice, Inbred C57BLMice, KnockoutMicroRNAsPancreatic DuctsPancreatic NeoplasmsPancreatitisSignal TransductionMicroRNAs

Identifiers

PMID31367007
PMCPMC6668398
OpenAlexW2966826412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.